During the past decade, National Research Center for Cardiac Surgery conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Research Center for Cardiac Surgery" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "National Research Center for Cardiac Surgery, Kazakhstan" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "Carmat SA" with 1 trials sponsored and "Erasmus Medical Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Center for Cardiac Surgery" #1 collaborator was "Ministry of Education and Science, Republic of Kazakhstan" with 3 trials as a collaborator, "Thoratec Corporation" with 2 trials as a collaborator, "Center for Life Sciences" with 1 trials as a collaborator, "Emergo" with 1 trials as a collaborator and "Eurasia Invest Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "National Research Center for Cardiac Surgery" are "Advanced Refractory Left Ventricular Heart Failure" (2 trials), "Heart Failure" (2 trials), "Sepsis" (2 trials), "Acute Bronchitis" (1 trials) and "Acute Heart Failure" (1 trials). Many other conditions were trialed in "National Research Center for Cardiac Surgery" in a lesser frequency.

Most popular intervention types in "National Research Center for Cardiac Surgery" are "Device" (8 trials), "Diagnostic Test" (2 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "A shape-memory ring for adjustable gastric banding" (1 trials), "Aspirin 100mg" (1 trials), "CARMAT TAH" (1 trials), "Clinical and functional analysis" (1 trials) and "CytoSorb (CytoSorbents Corp., USA) - an extracorporeal cytokine adsorber" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Research Center for Cardiac Surgery" are 13 trials for "All" genders.

Currently, there are NaN active trials in "National Research Center for Cardiac Surgery". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in National Research Center for Cardiac Surgery, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Research Center for Cardiac Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".